Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 10841-10849

  Lu, Chi Wei ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING AFFINITY; CELL FUSION; CONFORMATION; MEMBRANE FUSION; MURINE LEUKEMIA VIRUS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS INFECTIVITY;

ANIMALS; CELL LINE; LEUKEMIA VIRUS, MURINE; MEMBRANE FUSION; MICE; POINT MUTATION; PROTEIN CONFORMATION; RECEPTORS, VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

EID: 0141789697     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.10841-10849.2003     Document Type: Article

References (52)

1. Anguliar, H. C., W. F. Anerson, and P. Cannon. 2003. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R peptide. J. Virol. 77:1281-1291.
2. Bae, Y., S. M. Kingsman, and A. Kingsman. 1997. Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J. Virol. 71:2092-2099.
3. Barnett, A., D. Wensel, W. Li, D. Fass, and J. M. Cunningham. 2003. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J. Virol. 77:2717-2729.
4. Barnett, A. L., and J. M. Cunningham. 2001. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J. Virol. 75:9096-9105.
5. Barnett, A. L., R. A. Davey, and J. M. Cunningham. 2001. Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc. Natl. Acad. Sci. USA 98:4113-4118.
6. Battini, J.-L., J. M. Heard, and O. Danos. 1992 Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66:1468-1475.
7. Brown, E. G., H. Liu, L. C. Kit, S. Baird, and M. Nesrallah, 2001. Patterns of mutation in the genome of influenza A virus on adaptation to increase virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98:6883-6888.
8. Burkhart, M. D., S. C. Kayman, Y. He, and A. Pinter. 2003. Distinct mechanism of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU. J. Virol. 77:3993-4003.
9. Chen, C.-C., A. Rivera, N. Ron, J. P. Dougherty, and Y. Ron. 2001. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 97:886-894.
10. Damico, R. L., J. Crane, and P. Bates. 1998. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 95:2580-2585.
11. Eckert, D., and P. S. Kim. 2001. Mechanism of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
12. Eckert, D. M., V. N. Malashkevich, L. H. Hong, P. A. Carr, and P. S. Kim. 1999. Inhibiting HIV entry: discovery of D-peptide inhibitors that target the gp41 coil-coil pocket. Cell 99:103-115.
13. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. Britt. 1990. A neutralizable epitope common to the envelope glycoprotein of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
14. Fass, D., R. A. Davey, C. A. Harmson, P. S. Kim, J. Cunningham, and J. M. Berger. 1997. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277:1663-1666.
15. Fass, D., S. C. Harrison, and P. S. Kim. 1996. Retrovirus envelope domain at 1.7 A resolution. Nat. Struct. Biol. 3:465-468.
16. Fields, B. N., and D. M. Knipe, 1985. Virology, vol. 2. Raven Press, New York, N.Y.
17. Gray, K. D., and M. J. Roth. 1993. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J. Virol. 67:3489-3496.
18. Green, N., T. M. Shinnick, O. Witte, A. Ponticelli, J. G. Sutchliffe, and R. A. Lerner. 1981. Sequence-specific antibodies show that maturation of Moloney murine leukemia virus envelope protein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78:6023-6027.
19. Gummuluru, S., C. M. Kinsey, and M. Emerman. 2000. An in vitro rapid turn-over assay for human immunodeficiency virus type 1 replication selections for cell-to-cell spread of virus. J. Virol. 74:10882-10891.
20. Heard, J. M., and O. Danos, 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
21. Hernandez, L. D., R. J. Peters, S. E. Delos, J. A. T. Young, D. A. Agard, and J. M. White. 1997. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding protein of the ASLV envelope glycoprotein. J. Cell Biol. 139:1455-1464.
22. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
23. Igakura, T., J. C. Stinchcombe, P. C. Goon, G. P. Taylor, J. N. Weber, G. M. Griffiths, Y. P. Tanaka, M. Osame, and C. R. M. Bangham. 2003. Spread of HTLV-1 between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716.
24. Kadan, M. J., S. Strum, W. F. Anderson, and M. A. Eglitis, 1992. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66:2281-2287.
25. Kayman, S. C., H. Park, M. Saxon, and A. Pinter. 1999. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J. Virol. 73:1802-1808.
26. Lavillette, D., B. Boson, S. J. Russell, and F.-L. Cosset. 2001. Activation of membrane fusion by murine leukemia virus is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J. Virol. 75:3685-3695.
27. Lavillette, D., M. Maurice, C. Roche, S. J. Russell, M. Sitbon, and F.-L. Cosset. 1998. A proline-rich motif downstream of the receptor binding domain modulates conformation and fsogenicity of murine retroviral envelopes. J. Virol. 72:9955-9965.
28. Lavillette, D., A. Ruggieri, B. Boson, M. Maurice, and F.-L. Cossset. 2002. Relationship between SU subdomains that regulate the receptor-mediated transition from native (fusion-inhibited) to fusion-active conformation of the murine leukemia virus glycoprotein. J. Virol. 76:9673-9685.
29. Lavillette, D., A. Ruggieri, S. J. Russell, and F.-L. Cosset. 2000. Activation of a cell entry pathway common to type C mammalian retrovirues by soluble envelope fragments. J. Virol. 74:295-304.
30. Lu, C.-W. 2003. Ph.D. thesis. University of Medicine and Dentistry of New Jersey, Piscataway, N.J.
31. Lu, C.-W., L. O'Reilly, and M. J. Roth. 2003. G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency. J. Virol. 77:739-743.
32. Lu, C.-W., and M. J. Roth. 2001. Functional characterization of the N termini of murine leukemia virus envelope protein. J. Virol. 75:4345-4366.
33. Lu, C.-W., and M. J. Roth. 2003. Functional interaction between the N- and C-terminal domains of murine leukemia virus surface envelope protein. Virology 310:130-140.
34. Moore, J. P., J. A. McKeating, R. A. Weiss, and Q. J. Sattentau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142.
35. Ng, L. V., T. G. Wood, and R. B. Arlinghaus. 1982. Processing of the env gene products of Moloney murine leukemia virus. J. Gen. Virol. 59:329-343.
36. O'Reilly, L., and M. J. Roth. 2000. Second site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J. Virol. 74:899-913.
37. Peredo, C., L. O'Reilly, K. Gray, and M. J. Roth. 1996. Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J. Virol. 70:3142-3152.
38. Pinter, A., T.-E. Chen, A. Lowy, N. G. Cortez, and S. Silagi. 1986. Ecotropic murine leukemia virus-induced fusion of murine cells. J. Virol. 57:1048-1054.
39. Pinter, A., W. J. Honnen, J. S. Tung, P. V. O'Donnel, and U. Hammerling. 1982. Structure domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116:499-516.
40. Pinter, A., R. Kopelman, L. Zhiyong, S. Kayman, and D. A. Sanders. 1997. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of the thiol-disulfide exchange enzymes. J. Virol. 71:8073-8077.
41. Rein, A. 1982. Interference grouping of murine leukemia viruses: a distinct receptor for MCF-recombinant viruses in mouse cells. Virology. 120:251-257.
42. Sanders, D. A. 2000. Sulfhydryl involvement in fusion mechanisms, p. 483-514. In H. J. Hilderson and S, Fuller (ed.), Subcellular biochemistry: fusion of biological membranes and related problems, vol. 34. Kluwer Academic/Plenum Publishers, New York, N.Y.
43. Skehel, J., and D. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biol. Chem. 69:531-569.
44. Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D. Waterfield, J. M. White, I. A. Wilson, and D. C. Wiley. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA 79:968-972.
45. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:629-633.
46. Stegmann, T., J. M. White, and A. Helenius. 1990. Intermediates in influenza induced membrane fusion. EMBO J. 9:4231-4241.
47. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
48. Wu, B. W., P. M. Cannon, E. M. Gordon, F. L. Hall, and W. F. Anderson. 1998. Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72:5385-5391.
49. Wu, B. W., J. Lu, T. K. Gallaher, W. F. Anderson, and P. M. Cannon. 2000. Identification of regions in Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide. Virology 269:7-17.
50. Yu, H., C. E. Xia, and W. F. Anderson. 1998. Quantitation of MoMuLV envelope protein on the cell surface. Virology 243:415-422.
51. Zavorotinskaya, T., and L. M. Abritton. 1999. Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J. Virol. 73:5034-5042.
52. Zhao, Y., L. Zhu, C. A. Benedict, D. Chen, W. F. Anderson, and P. Cannon. 1998. Functional domains in the retroviral transmembrane protein. J. Virol. 72:5392-5398.